FTAI is up +138.36% since Oct ’23 pick Unlock All Top Buy Picks
$0.0050
+0.0010 (+25.00%)
At Close: May 31, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile
There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:
Click to get the best stock tips daily for free!

About Invion Limited

Invion Limited Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a chlorophyll-based photosensitizer to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of r... IVX.AX Profile

Golden Star

Ticker Date Change Price
OXM May 29 3.64% $106.80
UTZ May 29 2.43% $18.10
DVAX May 29 3.99% $11.53
GNTX May 28 1.66% $34.43
OHI May 20 4.76% $30.86
CNI May 16 0.600% $126.57
TTWO May 16 9.78% $146.08
RL May 15 11.92% $166.98
LNG May 14 0.235% $157.42
VCLT May 14 0.277% $75.73
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT